Carroll Financial Associates’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$1K Hold
16
﹤0.01% 1568
2021
Q3
$1K Hold
16
﹤0.01% 1678
2021
Q2
$1K Hold
16
﹤0.01% 1643
2021
Q1
$1K Hold
16
﹤0.01% 1579
2020
Q4
$1K Hold
16
﹤0.01% 1470
2020
Q3
$0 Hold
16
﹤0.01% 1613
2020
Q2
$0 Hold
16
﹤0.01% 1628
2020
Q1
$0 Hold
16
﹤0.01% 1593
2019
Q4
$1K Hold
16
﹤0.01% 1459
2019
Q3
$1K Hold
16
﹤0.01% 1433
2019
Q2
$1K Buy
+16
New +$1.61K ﹤0.01% 1484
2016
Q4
Sell
-3
Closed 1189
2016
Q3
$0 Buy
+3
New +$127 ﹤0.01% 1186

Other funds holding NGVT

Carroll Financial Associates's NGVT Position: Q4 2021 in Review

Carroll Financial Associates held its Ingevity (NGVT) position steady in Q4 2021 at 16 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

Carroll Financial Associates first reported a position in NGVT in Q3 2016 and has held it in 12 quarters since. 277 funds tracked by Wall St. Rank hold NGVT as of Q4 2021.

  • Carroll Financial Associates held 16 shares of Ingevity worth $1K as of Q4 2021.
  • Carroll Financial Associates left its Ingevity share count unchanged in Q4 2021.
  • Ingevity made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1568 holding.
  • Carroll Financial Associates first reported a position in Ingevity in Q3 2016 and has held it in 12 quarters since.
  • 277 funds tracked by Wall St. Rank held Ingevity as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.